3D biofabrication for tubular tissue engineering

Ian Holland; Jack Logan; Jiezhong Shi; Christopher McCormick; Dongsheng Liu; Wenmiao Shu

doi:10.1007/s42242-018-0013-2

3D biofabrication for tubular tissue engineering

Ian Holland, Jack Logan, Jiezhong Shi, Christopher McCormick, Dongsheng Liu, Wenmiao Shu

Research output: Contribution to journal › Article

Abstract

The therapeutic replacement of diseased tubular tissue is hindered by the availability and suitability of current donor, autologous and synthetically derived protheses. Artificially created, tissue engineered, constructs have the potential to alleviate these concerns with reduced auto-immune response, high anatomical accuracy, long term patency and growth potential. The advent of 3D bio-printing technology has further supplemented the technological toolbox, opening up new biofabrication research opportunities and expanding the therapeutic potential of the field. In this review, we highlight the challenges facing those seeking to create artificial tubular tissue with its associated complex macro and microscopic architecture. Current biofabrication approaches, including 3D printing techniques, are reviewed and future directions suggested.

Language	English
Number of pages	12
Journal	Bio-Design and Manufacturing
Early online date	23 May 2018
DOIs	10.1007/s42242-018-0013-2
Publication status	E-pub ahead of print - 23 May 2018

Fingerprint

Tissue Engineering

Technology

Therapeutics

Growth

Research

Three Dimensional Printing

Keywords

tubular organs
tissue engineering
3D printing
bio-inks

Cite this

Holland, I., Logan, J., Shi, J., McCormick, C., Liu, D., & Shu, W. (2018). 3D biofabrication for tubular tissue engineering. Bio-Design and Manufacturing. https://doi.org/10.1007/s42242-018-0013-2

Holland, Ian ; Logan, Jack ; Shi, Jiezhong ; McCormick, Christopher ; Liu, Dongsheng ; Shu, Wenmiao. / 3D biofabrication for tubular tissue engineering. In: Bio-Design and Manufacturing. 2018.

@article{4e85c22660b3401fb2a03077b949c99f,

title = "3D biofabrication for tubular tissue engineering",

abstract = "The therapeutic replacement of diseased tubular tissue is hindered by the availability and suitability of current donor, autologous and synthetically derived protheses. Artificially created, tissue engineered, constructs have the potential to alleviate these concerns with reduced auto-immune response, high anatomical accuracy, long term patency and growth potential. The advent of 3D bio-printing technology has further supplemented the technological toolbox, opening up new biofabrication research opportunities and expanding the therapeutic potential of the field. In this review, we highlight the challenges facing those seeking to create artificial tubular tissue with its associated complex macro and microscopic architecture. Current biofabrication approaches, including 3D printing techniques, are reviewed and future directions suggested.",

keywords = "tubular organs, tissue engineering, 3D printing, bio-inks",

author = "Ian Holland and Jack Logan and Jiezhong Shi and Christopher McCormick and Dongsheng Liu and Wenmiao Shu",

year = "2018",

month = "5",

day = "23",

doi = "10.1007/s42242-018-0013-2",

language = "English",

journal = "Bio-Design and Manufacturing",

issn = "2096-5524",

publisher = "Springer",

}

Holland, I , Logan, J , Shi, J , McCormick, C, Liu, D & Shu, W 2018, '3D biofabrication for tubular tissue engineering' Bio-Design and Manufacturing. https://doi.org/10.1007/s42242-018-0013-2

3D biofabrication for tubular tissue engineering. / Holland, Ian ; Logan, Jack ; Shi, Jiezhong ; McCormick, Christopher; Liu, Dongsheng; Shu, Wenmiao.

In: Bio-Design and Manufacturing, 23.05.2018.

Research output: Contribution to journal › Article

TY - JOUR

T1 - 3D biofabrication for tubular tissue engineering

AU - Holland, Ian

AU - Logan, Jack

AU - Shi, Jiezhong

AU - McCormick, Christopher

AU - Liu, Dongsheng

AU - Shu, Wenmiao

PY - 2018/5/23

Y1 - 2018/5/23

N2 - The therapeutic replacement of diseased tubular tissue is hindered by the availability and suitability of current donor, autologous and synthetically derived protheses. Artificially created, tissue engineered, constructs have the potential to alleviate these concerns with reduced auto-immune response, high anatomical accuracy, long term patency and growth potential. The advent of 3D bio-printing technology has further supplemented the technological toolbox, opening up new biofabrication research opportunities and expanding the therapeutic potential of the field. In this review, we highlight the challenges facing those seeking to create artificial tubular tissue with its associated complex macro and microscopic architecture. Current biofabrication approaches, including 3D printing techniques, are reviewed and future directions suggested.

AB - The therapeutic replacement of diseased tubular tissue is hindered by the availability and suitability of current donor, autologous and synthetically derived protheses. Artificially created, tissue engineered, constructs have the potential to alleviate these concerns with reduced auto-immune response, high anatomical accuracy, long term patency and growth potential. The advent of 3D bio-printing technology has further supplemented the technological toolbox, opening up new biofabrication research opportunities and expanding the therapeutic potential of the field. In this review, we highlight the challenges facing those seeking to create artificial tubular tissue with its associated complex macro and microscopic architecture. Current biofabrication approaches, including 3D printing techniques, are reviewed and future directions suggested.

KW - tubular organs

KW - tissue engineering

KW - 3D printing

KW - bio-inks

UR - https://link.springer.com/journal/42242

U2 - 10.1007/s42242-018-0013-2

DO - 10.1007/s42242-018-0013-2

M3 - Article

JO - Bio-Design and Manufacturing

T2 - Bio-Design and Manufacturing

JF - Bio-Design and Manufacturing

SN - 2096-5524